Control of anti-tuberculosis drug resistance in Botswana

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 1, 2003, Pages 72-77

  Talbot, Elizabeth A ^a,c   Kenyon, T A ^a   Mwasekaga, M J ^b   Moeti, T L ^b   Mallon, V ^a   Binkin, N J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c U S DEPARTMENT OF STATE   (United States)

Author keywords

Botswana; Drug resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ARTICLE; BOTSWANA; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM SMEAR; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; BOTSWANA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0037251667     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dye C, Scheele S, Dolin P, Pathanai V, Raviglione MC for the WHO Global Surveillance and Monitoring Project. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999; 282: 677-686.
2. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in six countries. JAMA 2000; 283: 2537-2545.
3. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for anti-tuberculosis drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
4. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to anti-tuberculosis drugs. N Engl J Med 2001; 344: 1294-1303.
5. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. WHO/TB/97.220. Geneva: WHO, 1997.
6. Botswana National Tuberculosis Programme. National Tuberculosis Programme Manual. 5th ed. Gaborone, Botswana: Ministry of Health, 1995.
7. Epidemiology and Disease Control Unit, Botswana Ministry of Health. Evaluation of the Botswana National Tuberculosis Programme. Gaborone, Botswana: Ministry of Health, 1999.
8. Botswana National Tuberculosis Programme. 2000 Annual Report. Gaborone, Botswana: Botswana Ministry of Health, 2000.
9. Sentinel Surveillance Report 2000. AIDS/STD Unit Report, Gaborone: AIDS/STD Unit, Republic of Botswana Ministry of Health, 2001.
10. Kenyon T A, Mwasekaga M J, Huebner R, Ramisha D, Binkin N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 1999; 3: 4-11.
11. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/96.216. Geneva: WHO, 1996.
12. International Union Against Tuberculosis and Lung Disease. Technical guide for sputum examination for tuberculosis by direct microscopy. Bull Int Union Tuberc 1978; 53 (Suppl 2): 1-16.
13. Mitchison D A. Bacteriology of tuberculosis. Trop Doct 1974; 4: 147-153.
14. Tshukamura M, Tshukamura S. Differentiation of M. tuberculosis and M. bovis by p-nitrobenzoic acid susceptibility. Tubercle 1964; 45: 64-65.
15. Virtanen S. A study of nitrate reduction by mycobacteria. Acta Tuberc Scand 1960; 48 (Suppl): 1-119.
16. Wayne L G, Doubek J R, Russell R L. Tests employing Tween 80 as substrate. Am Rev Respir Dis 1964; 90: 588-597.
17. Kubica G P, Rigdon A L. Preliminary investigation of rapidly growing acid-fast bacilli. Am Rev Respir Dis 1961; 83: 737-740.
18. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
19. Mosimaneotsile B, Moalosi G, Moeti T L, et al. Validation of the screening algorithm for isoniazid preventive therapy (IPT) for HIV-infected persons, Botswana, 2000-2001. [Abstract] Presented at the IUATLD Conference, Paris, Nov 1-4, 2001. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S40.
20. Mahmoudi A, Iseman M D. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68.
21. Chaisson R E, Coberly J S, De Cock K M. DOTS and drug resistance: a silver lining to a darkening cloud. Int J Tuberc Lung Dis 1999; 3: 1-3.
22. Cantwell M, Binkin N J. Impact of HIV on tuberculosis control in sub-Saharan Africa: a regional perspective. Tubercle Lung Dis 1997; 3: 205-214.
23. WHO/UNAIDS. Policy statement on preventive therapy against tuberculosis in people living with HIV. WHO/TB/ 98.255. Geneva: WHO, 1998.
24. World Health Organization. Tuberculosis handbook. WHO/ TB/98.253. Geneva: WHO, 1998.